NDC 72934- 5010-4 BENZOCAINE 20% / LIDOCAINE 8% / TETRACAINE 4%.- ndc 72934- 5010-4 benzocaine 20% / lidocaine 8% / tetracaine 4%. ointment
Sincerus Florida, LLC

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

----------

BENZOCAINE 20% / LIDOCAINE 8% / TETRACAINE 4%.

Directions for use

Sincerus Florida, LLC. Adverse reactions

Active, inactive

NDC 72934- 5010-4 BENZOCAINE USP 20% / LIDOCAINE USP 8% / TETRACAINE USP 4%. Ointment 120gm

NDC 72934- 5010-4 BENZOCAINE 20% / LIDOCAINE 8% / TETRACAINE 4%.
ndc 72934- 5010-4 benzocaine 20% / lidocaine 8% / tetracaine 4%. ointment

Product Information
Product Type	HUMAN PRESCRIPTION DRUG	Item Code (Source)	NDC:72934-5010
Route of Administration	TOPICAL

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
BENZOCAINE (UNII: U3RSY48JW5) (BENZOCAINE - UNII:U3RSY48JW5)	BENZOCAINE	20 g in 100 g
LIDOCAINE (UNII: 98PI200987) (LIDOCAINE - UNII:98PI200987)	LIDOCAINE	8 g in 100 g
TETRACAINE (UNII: 0619F35CGV) (TETRACAINE - UNII:0619F35CGV)	TETRACAINE	4 g in 100 g

Product Characteristics
Color	white	Score
Shape		Size
Flavor		Imprint Code
Contains

#	Item Code	Package Description	Marketing Start Date	Marketing End Date
Packaging
1	NDC:72934-5010-4	120 g in 1 BOTTLE, PUMP; Type 0: Not a Combination Product	05/17/2019

Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
Marketing Information
unapproved drug other		05/17/2019

Labeler - Sincerus Florida, LLC (080105003)

Name	Address	ID/FEI	Business Operations
Establishment
Sincerus Florida, LLC		080105003	manufacture(72934-5010)